SKIV2L (Homo sapiens) in pDONR221 (Gateway donor/master vector)

Explanation of Terms

Gene:
Gene Symbol:  SKIV2L
Gene Name:  superkiller viralicidic activity 2-like (S. cerevisiae)
Original Clone ID:
FLH184615.01L
Keyword:
None
Species:
Homo sapiens
Type:
cDNA
Vector Name:
pDONR221
Format: 
FUSION
Source:
HIP
Description:
None
Comments:
None
Mutation / Discrepancy:
No / Yes
Publications:
None
Authors:
HIP
HsCD00076156
Price: 
Login for Pricing
AVAILABLE
No restriction
Special MTA: None
Insert sequence: 3738nts
Open reading frame: 1 to 3738

ATGATGGAGACAGAGCGACTTGTGCTACCCCCTCCAGATCCCCTGGACCTACCCCTTCGG
GCCGTGGAGCTCGGATGCACGGGGCACTGGGAGCTGCTGAACTTGCCTGGAGCTCCAGAG
AGTAGCCTTCCCCATGGCCTCCCTCCTTGTGCCCCAGATCTGCAGCAAGAAGCAGAACAG
TTGTTTCTGTCATCCCCAGCCTGGCTGCCTCTGCATGGTGTGGAGCACTCAGCCCGAAAA
TGGCAGAGGAAGACGGATCCCTGGTCTCTTTTGGCTGTGCTGGGAGCCCCAGTCCCATCC
GACCTACAGGCCCAAAGACACCCAACCACAGGCCAGATACTGGGTTACAAAGAGGTCTTG
CTGGAGAACACAAATCTCTCGGCTACAACCTCCTTGTCTCTTCGCCGGCCTCCAGGGCCA
GCCTCCCAGTCCTTATGGGGAAATCCAACTCGGTATCCCTTCTGGCCAGGGGGGATGGAT
GAACCCACCATAACAGATCTGAACACACGGGAGGAGGCTGAGGAGGAGATAGACTTTGAG
AAAGATCTTCTTACTATTCCACCTGGTTTCAAGAAAGGCATGGACTTTGCACCAAAAGAT
TGTCCAACTCCAGCTCCTGGACTACTAAGCCTTAGCTGTCTGTTGGAGCCTCTGGATTTG
GGTGGGGGTGACGAGGATGAGAATGAGGCAGTGGGACAGCCAGGAGGTCCCAGAGGGGAC
ACTGTTTCAGCCTCTCCCTGCAGTGCTCCCCTGGCCCGAGCAAGCAGCTTGGAAGACCTA
GTGTTGAAGGAAGCGTCCACAGCTGTATCCACCCCAGAGGCCCCAGAGCCTCCATCTCAG
GAGCAGTGGGCCATCCCTGTGGACGCCACCTCCCCTGTTGGTGATTTCTATCGCCTCATT
CCCCAGCCAGCCTTCCAGTGGGCATTTGAGCCAGATGTGTTTCAGAAACAGGCCATCCTG
CACTTGGAACGGCATGACTCTGTCTTTGTCGCAGCTCACACATCTGCAGGAAAAACAGTT
GTGGCTGAATATGCCATTGCCCTGGCCCAGAAACACATGACACGCACCATCTACACTTCG
CCCATCAAGGCCCTGAGCAACCAGAAGTTCCGGGACTTCCGAAACACATTCGGGGATGTG
GGGCTGCTCACCGGGGATGTACAGCTGCATCCGGAGGCCTCCTGCCTCATCATGACCACA
GAGATCCTTCGCTCCATGCTGTACAGTGGCTCAGATGTTATTCGGGACCTGGAGTGGGTC
ATCTTTGATGAGGTTCACTATATCAACGATGTCGAGCGTGGGGTCGTGTGGGAGGAGGTG
CTTATCATGCTACCTGACCACGTTTCTATCATCCTTCTGAGTGCCACCGTCCCCAACGCC
CTTGAGTTTGCTGACTGGATTGGGCGGCTGAAGCGTCGTCAGATCTATGTGATTAGCACT
GTAACCCGCCCCGTGCCCCTGGAGCACTATCTTTTCACAGGGAACAGCTCCAAGACCCAG
GGGGAGCTCTTTTTGTTGCTGGACTCCCGAGGAGCCTTCCATACAAAAGGGTACTATGCA
GCTGTGGAGGCCAAGAAGGAGAGAATGAGCAAACACGCCCAGACCTTTGGGGCCAAGCAG
CCCACACATCAGGGGGGCCCTGCACAGGACCGCGGAGTGTACCTGTCCCTCCTGGCCTCC
CTCCGCACACGTGCCCAGTTGCCCGTGGTGGTGTTCACCTTCTCCCGGGGCCGCTGTGAT
GAGCAGGCCTCAGGCCTCACCTCCCTTGACCTCACCACCAGTTCGGAGAAGAGCGAGATC
CACCTCTTCCTGCAGCGCTGCCTTGCTCGCCTCCGTGGCTCTGACCGCCAGCTGCCCCAG
GTCCTGCACATGTCAGAGCTCCTGAATCGCGGCCTGGGTGTGCACCATAGCGGCATCCTG
CCCATCCTCAAGGAGATCGTGGAGATGCTCTTCAGCCGTGGCCTGGTCAAGGTCTTGTTT
GCCACAGAGACCTTTGCCATGGGAGTAAACATGCCTGCTCGTACAGTAGTGTTTGACTCC
ATGCGCAAACACGATGGCTCCACCTTCCGGGACCTGCTCCCTGGGGAGTATGTGCAGATG
GCAGGCCGGGCAGGGCGGAGGGGCCTGGACCCCACAGGCACCGTTATCCTGCTCTGCAAG
GGCCGAGTGCCCGAGATGGCAGACCTGCACCGCATGATGATGGGGAAGCCGTCCCAGCTG
CAGTCCCAGTTCCGCCTCACGTACACTATGATCCTCAACTTGCTGCGAGTGGATGCCCTC
AGGGTGGAGGACATGATGAAGAGGAGCTTCTCTGAGTTTCCCTCCCGCAAAGACAGCAAG
GCCCATGAACAGGCCCTGGCTGAACTGACCAAGAGGCTGGGAGCTTTGGAGGAGCCTGAC
ATGACTGGCCAACTGGTCGACCTGCCTGAATATTACAGCTGGGGGGAGGAACTGACAGAG
ACCCAGCACATGATCCAGCGACGCATCATGGAGTCTGTGAACGGGCTGAAGTCTCTCTCA
GCAGGAAGGGTGGTGGTTGTGAAGAATCAGGAGCATCACAACGCATTGGGAGTGATCCTA
CAGGTCTCCTCGAACTCCACCAGCAGAGTATTCACAACCCTGGTCTTGTGTGATAAGCCC
TTGTCCCAGGACCCACAGGACAGGGGGCCAGCCACTGCAGAGGTGCCCTATCCAGATGAC
CTCGTGGGATTCAAGCTGTTCCTGCCTGAAGGGCCTTGTGACCACACCGTGGTCAAGCTC
CAGCCAGGAGATATGGCTGCCATCACCACCAAGGTGCTCCGGGTGAATGGGGAGAAGATC
TTGGAGGACTTCAGCAAGAGGCAGCAGCCAAAATTCAAGAAGGATCCTCCCCTTGCAGCC
GTGACCACTGCTGTCCAGGAACTGCTGCGTCTGGCTCAGGCCCACCCAGCCGGACCTCCC
ACCCTCGACCCTGTCAATGACCTGCAGCTCAAAGATATGTCAGTTGTAGAGGGTGGGCTC
CGGGCCCGGAAGCTGGAGGAGCTGATCCAGGGGGCTCAGTGTGTACACAGCCCCCGTTTT
CCTGCCCAGTACCTGAAGCTGCGGGAGCGAATGCAGATACAGAAGGAGATGGAGCGGCTG
CGCTTCCTACTGTCGGATCAGTCATTGCTGCTGCTTCCTGAGTACCATCAGCGAGTAGAG
GTGCTCCGAACCCTGGGTTACGTGGACGAGGTGGGCACTGTGAAGCTGGCAGGGCGGGTG
GCTTGTGCCATGAGCAGCCATGAGTTGCTCCTCACTGAGCTCATGTTTGACAATGCACTG
AGCACCCTGCGGCCTGAGGAGATTGCTGCCTTGCTCTCTGGCCTGGTCTGCCAGAGCCCT
GGGGACGCTGGGGATCAGCTCCCAAACACCCTCAAGCAGGGAATAGAACGTGTCCGGGCT
GTGGCCAAGCGGATTGGTGAGGTCCAGGTGGCTTGTGGCCTGAACCAGACGGTGGAGGAA
TTTGTGGGGGAGCTGAATTTTGGGCTGGTTGAGGTTGTATATGAGTGGGCCCGGGGCATG
CCCTTCTCCGAGTTGGCAGGGCTCTCAGGGACCCCTGAGGGCCTGGTGGTCCGCTGCATT
CAGCGCCTGGCTGAGATGTGTCGCTCACTGCGGGGGGCAGCCCGCCTGGTAGGAGAGCCT
GTGCTGGGTGCCAAGATGGAGACAGCGGCTACCTTGCTACGGCGGGACATCGTATTTGCG
GCCAGCCTCTACACCCAG

Protein sequence predicted based on nucleotide sequence

MMETERLVLPPPDPLDLPLRAVELGCTGHWELLNLPGAPESSLPHGLPPCAPDLQQEAEQ
LFLSSPAWLPLHGVEHSARKWQRKTDPWSLLAVLGAPVPSDLQAQRHPTTGQILGYKEVL
LENTNLSATTSLSLRRPPGPASQSLWGNPTRYPFWPGGMDEPTITDLNTREEAEEEIDFE
KDLLTIPPGFKKGMDFAPKDCPTPAPGLLSLSCLLEPLDLGGGDEDENEAVGQPGGPRGD
TVSASPCSAPLARASSLEDLVLKEASTAVSTPEAPEPPSQEQWAIPVDATSPVGDFYRLI
PQPAFQWAFEPDVFQKQAILHLERHDSVFVAAHTSAGKTVVAEYAIALAQKHMTRTIYTS
PIKALSNQKFRDFRNTFGDVGLLTGDVQLHPEASCLIMTTEILRSMLYSGSDVIRDLEWV
IFDEVHYINDVERGVVWEEVLIMLPDHVSIILLSATVPNALEFADWIGRLKRRQIYVIST
VTRPVPLEHYLFTGNSSKTQGELFLLLDSRGAFHTKGYYAAVEAKKERMSKHAQTFGAKQ
PTHQGGPAQDRGVYLSLLASLRTRAQLPVVVFTFSRGRCDEQASGLTSLDLTTSSEKSEI
HLFLQRCLARLRGSDRQLPQVLHMSELLNRGLGVHHSGILPILKEIVEMLFSRGLVKVLF
ATETFAMGVNMPARTVVFDSMRKHDGSTFRDLLPGEYVQMAGRAGRRGLDPTGTVILLCK
GRVPEMADLHRMMMGKPSQLQSQFRLTYTMILNLLRVDALRVEDMMKRSFSEFPSRKDSK
AHEQALAELTKRLGALEEPDMTGQLVDLPEYYSWGEELTETQHMIQRRIMESVNGLKSLS
AGRVVVVKNQEHHNALGVILQVSSNSTSRVFTTLVLCDKPLSQDPQDRGPATAEVPYPDD
LVGFKLFLPEGPCDHTVVKLQPGDMAAITTKVLRVNGEKILEDFSKRQQPKFKKDPPLAA
VTTAVQELLRLAQAHPAGPPTLDPVNDLQLKDMSVVEGGLRARKLEELIQGAQCVHSPRF
PAQYLKLRERMQIQKEMERLRFLLSDQSLLLLPEYHQRVEVLRTLGYVDEVGTVKLAGRV
ACAMSSHELLLTELMFDNALSTLRPEEIAALLSGLVCQSPGDAGDQLPNTLKQGIERVRA
VAKRIGEVQVACGLNQTVEEFVGELNFGLVEVVYEWARGMPFSELAGLSGTPEGLVVRCI
QRLAEMCRSLRGAARLVGEPVLGAKMETAATLLRRDIVFAASLYTQ

Coding Sequence Details

Insert Sequence Verified?:
Y
Verification Method:
Sequence Verification
Reference Sequence Annotations:
Start on reference sequence 3
End on reference sequence 3743
Mutations:
None
Discrepancy:
g9t,E3D
                                                    

5' Linker Sequence:
None
3' Linker Sequence:
None

Recommended Growth Condition:

Distributed in bacterial strain:
DH5-alpha T1 phage resistant
Antibiotic Selection:
Host Type:  bacterial    Marker:  kanamycin
Bacterial Selection Condition: 50ug/mL kanamycin
Growth Condition: Growth with the single antibiotic in LB at 37 degrees is recommended.
Comments: Conditions for Gateway-type vectors in recombined (with insert) form and other kanamycin resistant vectors.
Protein Expression Results:
None
Recommended expression in:
Not Applicable